Avitide Receives Series D Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=56a50a60-ee82-48f7-b8da-952e38f0d922
Date
9/13/2016
Company Name
Avitide
Mailing Address
16 Cavendish Court Lebanon, NH 03766 USA
Company Description
Avitide develops customized biopharmaceutical affinity purification products with an industry-leading discovery and development service time
Website
http://www.avitide.com
Transaction Type
Venture Equity
Transaction Amount
Undisclosed
Transaction Round
Series D
Proceeds Purposes
Proceeds from this financing will allow us broaden and deepen existing relationships, embark on new strategic initiatives, and support our growing roster of partnered programs and novel affinity separation products,” said Kevin Isett, CEO and Co-Founder of Avitide.
M&A Terms
Venture Investor
Mithril Capital Management
Venture Investor
Undisclosed